SJS Investment Consulting’s Quest Diagnostics DGX Stock Holding History

SJS Investment Consulting’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$63K	Buy	297 +21	+8%	+$4.12K	0.01%	356
2026 Q1	$54.1K	Buy	276 +4	+1%	+$777	0.01%	358
2025 Q4	$47.2K	Buy	272 +1	+0.4%	+$182	0.01%	383
2025 Q3	$51.6K	Buy	271 +262	+2,911%	+$46.5K	0.01%	274
2025 Q2	$1.62K	Sell	9 -8	-47%	-$1.39K	﹤0.01%	638
2025 Q1	$2.88K	Sell	17 -4	-19%	-$657	﹤0.01%	594
2024 Q4	$3.19K	Sell	21 -1	-5%	-$156	﹤0.01%	544
2024 Q3	$3.43K	Buy	22 +1	+5%	+$149	﹤0.01%	579
2024 Q2	$2.88K	Hold	21	–	–	﹤0.01%	582
2024 Q1	$2.8K	Buy	21 +10	+91%	+$1.3K	﹤0.01%	616
2023 Q4	$1.52K	Sell	11 -3	-21%	-$394	﹤0.01%	779
2023 Q3	$1.71K	Buy	14 +4	+40%	+$533	﹤0.01%	701
2023 Q2	$1.41K	Sell	10 -5	-33%	-$689	﹤0.01%	757
2023 Q1	$2.12K	Sell	15 -9	-38%	-$1.29K	﹤0.01%	583
2022 Q4	$3.75K	Buy	24 +12	+100%	+$1.72K	﹤0.01%	413
2022 Q3	$1K	Buy	+12	New	+$1.58K	﹤0.01%	679
2022 Q1	$0	Buy	+3	New	+$418	﹤0.01%	848

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

MGP

M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SJS Investment Consulting's DGX Position: Q2 2026 in Review

SJS Investment Consulting increased its Quest Diagnostics (DGX) stake by 7.6% in Q2 2026, buying an estimated $4.12K and bringing the position to 297 shares worth $63K. The position accounts for 0.01% of the portfolio, ranked #356.

SJS Investment Consulting first reported a position in DGX in Q1 2022 and has held it in 17 quarters since. 678 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

SJS Investment Consulting held 297 shares of Quest Diagnostics worth $63K as of Q2 2026.
SJS Investment Consulting bought 21 Quest Diagnostics shares in Q2 2026, an estimated $4.12K.
Quest Diagnostics made up 0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #356 holding.
SJS Investment Consulting first reported a position in Quest Diagnostics in Q1 2022 and has held it in 17 quarters since.
678 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.